Direkt zum Inhalt
Merck
  • The antioxidant action of a pure antioestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17 beta-oestradiol and relevance to its anticancer potential.

The antioxidant action of a pure antioestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17 beta-oestradiol and relevance to its anticancer potential.

Biochemical pharmacology (1994-02-09)
H Wiseman
ZUSAMMENFASSUNG

The pure antioestrogen ICI 164,384, and nafoxidine (structurally related to tamoxifen) were good inhibitors of iron ion-dependent lipid peroxidation. In rat liver microsomes incubated with Fe(III)-ascorbate the overall order of effectiveness of the compounds tested as inhibitors of lipid peroxidation was 4-hydroxytamoxifen > 17 beta-oestradiol > nafoxidine > or = tamoxifen > ICI 164,384. When the microsomes were incubated with Fe(III)-ADP/NADPH, a similar order of effectiveness was observed. In ox-brain phospholipid liposomes incubated with Fe(III)-ascorbate the order was 4-hydroxytamoxifen > 17 beta-oestradiol > ICI 164,384 > tamoxifen > or = nafoxidine. The antioxidant ability of ICI 164,384, a steroidal oestrogen antagonist, is compared to that of tamoxifen (a non-steroidal antioestrogen and partial oestrogen agonist) and 17 beta-oestradiol and is discussed in relation to its anticancer action.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Nafoxidine hydrochloride, ≥98% (HPLC)